SCHEMBL4474111

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL744719	0.82	—	—
	SCHEMBL3596573	0.79	MMP13 (0.55)	HDAC6HPGDRAB9ANPC1KMT2A
	SCHEMBL4484954	0.78	NPC1 (0.40)	CNR1HPGDKDM4ERAB9AHTT
	SCHEMBL743243	0.74	—	—
	SCHEMBL1444391	0.73	—	—
	SCHEMBL17028993	0.72	ALDH1A1 (0.46)	HPGDL3MBTL1RAB9ALMNAHTT
	SCHEMBL28226304	0.72	MAP3K5 (0.52)	CNR1HDAC4HDAC1HDAC6HPGD
	SCHEMBL971766	0.72	MAPT (0.50)	HPGDRAB9ANPC1KMT2AGAA
	SCHEMBL742184	0.71	—	—
	SCHEMBL2653139	0.71	CDC7 (0.32)	HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.